On July 30, Teradyne rose 8.37% in regular trading, trading at $349.93/share, with turnover of $73.26 million, extending post-earnings momentum.

On the news front, the company previously reported Q2 results that significantly beat market expectations. Q2 adjusted EPS came in at $2.47, far exceeding the consensus estimate of $2.09. Revenue reached $1.33 billion, up 104% year-over-year, surpassing the expected $1.22 billion. The semiconductor test segment contributed $1.122 billion, driven by surging AI chip testing demand. Net income reached $374.5 million, compared to $78.4 million in the year-ago period. Q3 guidance was equally robust, with revenue projected at $1.2 billion to $1.3 billion versus the Street estimate of $1.06 billion, and adjusted EPS midpoint of $2.00, well above the consensus of $1.44.

Additionally, multiple investment banks raised their price targets: JPMorgan adjusted to $465 from $450 maintaining Overweight, Cantor Fitzgerald raised to $550 from $400 maintaining Overweight, and UBS lifted to $500 from $440 maintaining Buy, reflecting strong institutional confidence in AI-driven growth prospects.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)